Geographic Variation in Obesity at the State Level in the All of Us Research Program
ORIGINAL RESEARCH — Volume 18 — December 23, 2021
PEER REVIEWED
Figure 1 displays a map of the prevalence of obesity (BMI of 30 or above) in each of the 50 US states, as calculated by the All of Us Research Program. US territories are not shown. Prevalence estimates were 20.4%–30% in Maryland, North Carolina, Oregon, and Washington State; 30.1%–35% in California, Louisiana, Missouri, New Jersey, and Utah; 35.1%–40% in Colorado, Florida, Massachusetts, Minnesota, Nebraska, Nevada, New Mexico, New York, and North Dakota; 40.1%–45% in Arkansas, Georgia, Illinois, Kansas, Michigan, Pennsylvania, and Wisconsin; 45.1%–50% in Arizona, Indiana, and Texas; 50.1%–55.6% in Alabama, Connecticut, Mississippi, South Carolina, and Tennessee. The remaining states had fewer than 100 participants and were not included in the analysis.
Figure 1.
Prevalence of obesity in the US among the All of Us Research Program cohort with a calculated body mass index (kg/m2) of 30 or above, based on physical measurement data. Prevalence estimates were not calculated for states with fewer than 100 participants.
Figure 2 displays a map of the prevalence of severe obesity (BMI of 35 or above) in each of the 50 US states. US territories are not shown. Prevalence estimates were 8.8% to 12% in New Jersey, North Carolina, Oregon, and Washington State; 12.1% to 15% in Louisiana, Maryland, Missouri, Nevada, and Utah; 15.1% to 17% in California, Kansas, Minnesota, and New York; 17.1% to 21% in Colorado, Florida, Georgia, Illinois, Massachusetts, Nebraska, New Mexico, North Dakota, and Wisconsin; 21.1% to 30% in Arizona, Arkansas, Connecticut, Indiana, Michigan, Pennsylvania, and Texas; and 30.1% to 33.2% in Alabama, Mississippi, South Carolina, and Tennessee. The remaining states had fewer than 100 participants and were not included in the analysis.
Figure 2.
Prevalence of severe obesity in the All of Us Research Program, calculated BMI of 35 kg/m2 or above, based on physical measurement data. Prevalence estimates were not calculated for states with fewer than 100 participants.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.